Background/Aims: The accumulation of free cholesterol in atherosclerotic lesions has been well documented in both animals and humans. In studying the relevance of free cholesterol buildup in atherosclerosis, contradictory results have been generated, indicating that free cholesterol produces both pro-and anti-atherosclerosis effects in macrophages. This inconsistency might stem from the examination of only select concentrations of free cholesterol. In the present study, we sought to investigate the implication of excess free cholesterol loading in the pathophysiology of atherosclerosis across a broad concentration range from (in µg/ml) 0 to 60. Methods: Macrophage viability was determined by measuring formazan formation and flow cytometry viable cell counting. The polarization of M1 and M2 macrophages was differentiated by FACS (Fluorescence-Activated Cell Sorting) assay. The secretion of IL-1β in macrophage culture medium was measured by ELISA kit. Macrophage apoptosis was detected by flow cytometry using a TUNEL kit. Results: Macrophage viability was increased at the treatment of lower concentrations of free cholesterol from (in µg/ml) 0 to 20, but gradually decreased at higher concentrations from 20 to 60. Lower free cholesterol loading induced anti-inflammatory M2 macrophage polarization. The activation of the PPARγ (Peroxisome Proliferator-Activated Receptor gamma) nuclear factor underscored the stimulation of this M2 phenotype. Nevertheless, higher levels of free cholesterol resulted in pro-inflammatory M1 activation. Moreover, with the application of higher free cholesterol concentrations, macrophage apoptosis and secretion of the inflammatory cytokine IL-1β increased significantly. Conclusion: These results for the first time demonstrate that free cholesterol could render concentration-dependent diversification effects on macrophage viability, polarization, apoptosis and inflammatory cytokine secretions, thereby reconciling the pros and cons of free cholesterol buildup in macrophages to the pathophysiology of atherosclerosis.
Introduction
In atherosclerosis, oxLDL (oxidized Low-Density Lipoprotein) is taken up by lesional macrophages through scavenger receptors such as scavenger receptor class A and CD36 (Cluster of Differentiation 36) and then delivered to endo/lysosomes [1, 2] , where the cholesteryl ester is hydrolyzed to free cholesterol. Under normal conditions, the resultant free cholesterol could be reversely mobilized out of macrophages by ATP-binding cassette transporters A1, G1, B4 or SR-BI (Scavenger Receptor class B type I) or re-esterified via ACAT1 (acyl-coenzyme A:cholesterol acyltransferase 1) to cholesteryl ester and stored as cytoplasmic lipid droplets [3] [4] [5] . Disturbances in cholesterol metabolism and trafficking could induce both free cholesterol and cholesteryl ester accumulation in macrophages. Biochemical analyses of cholesterol components from atherosclerotic lesions at various stages of development reveal that little to no free cholesterol accumulates in the initial fatty streak phase, but this un-esterified cholesterol steadily increases with atheroma advancement in both animals and humans while cholesteryl ester gradually decreases [6] [7] [8] . The significant accumulation of free cholesterol in resident macrophages from advanced atherosclerotic lesions has been well documented [9] [10] [11] . Whereas cholesteryl ester is exclusively deposited as lipid droplets in macrophages and produces a foam cell morphology [12, 13] , free cholesterol accumulates at various locations along the free cholesterol trafficking pathway, such as the lysosomal lumen, plasma membrane, mitochondria and endoplasmic reticulum membranes [14] , and the cytoplasm as crystal precipitates [15] . Given that plasma membrane integrity and proper functioning of subcellular organelles are prerequisites for maintaining normal cell operation, excessive incorporations of free cholesterol into subcellular constituents will exert significant adverse effects on macrophage viability [16] [17] [18] . As well, a number of studies have shown that free cholesterol promotes inflammation and leads to macrophage apoptosis via mechanisms associated with cell membrane Fas activation [19] and mitochondria [20] or endoplasmic reticulum-induced programed cell death [8] . These findings are consistent with observations of increased macrophage apoptosis and necrosis in advanced atherosclerotic lesion cores.
However, other studies have demonstrated that free cholesterol prevents macrophages from expressing inflammatory-response genes [21, 22] . It has been found that free cholesterol buildup elevates desmosterol, an intermediate metabolite in cholesterol biosynthesis. This desmosterol serves as a ligand to initiate the LXR (Liver X Receptor)-mediated signaling cascade, which in turn suppresses inflammatory-response cytokines, including IL-1β, CXCL 9 [Chemokine (C-X-C motif) Ligand 9] , and CXCL 10, and blunts TLRs (Toll-Like Receptors) inflammatory signaling [23] . These results suggest that free cholesterol accumulation suppresses rather than promotes inflammation in macrophages and has protective effects against atherogenesis.
It is noteworthy that only limited concentrations of free cholesterol were examined in drawing these pro-and anti-inflammatory conclusions. Given that the buildup of cholesterol in macrophages plays a major role in atheroma development, the pathophysiological significance of free cholesterol to macrophages in atherosclerosis should be examined across a broad concentration range. The present study was designed to investigate the effects of free cholesterol accumulation on macrophage viability, pro-inflammatory M1 and anti-inflammatory M2 macrophage polarization, and inflammatory cytokine secretion in a wide free cholesterol concentration setting. We found that at lower concentrations free cholesterol increased macrophage viability and M2 macrophage polarization; while at higher concentrations, free cholesterol led to increased M1 activation, IL-1β secretion, and macrophage apoptosis. These results indicate that free cholesterol has concentrationdependent diversification effects in the pathophysiology of atherosclerosis. Understanding these diversified free cholesterol effects will facilitate the development of cholesteroltargeting approaches for the prevention and treatment of atherosclerosis.
Primary Culture of Mouse Bone Marrow-Derived Macrophages
The collection and differentiation of mouse bone marrow cells into macrophages were conducted following published methods [24, 25] . In brief, mice femur and tibia bones were dissected and their medullary cavities were flushed with RPMI-1640 medium to collect bone marrow cells. After two washes with PBS, the cells were cultured in RPMI-1640 medium supplemented with 15% L-929 conditional medium, 10% FBS and 1% streptomycin/penicillin; 37 o C, 5% CO 2 . The identity of differentiated macrophages was confirmed by positive immunostaining of CD68. 12 hours prior to experimentation, the macrophages were gently scraped to make subcultures and the following protocols were applied.
Confocal Microscopy Imaging of Cholesteryl Ester and Free Cholesterol Accumulation
Macrophages were subcultured into 8-well chamber slides at 2×10 4 cells/well. After 12 h of free cholesterol treatment, these cells underwent fluorescent staining according to published methods [26, 27] . In brief, the macrophages were fixed in 4% paraformaldehyde, washed three times in PBS, and then simultaneously treated with bodipy 493/503 and filipin at concentrations of 2.5 µM and 50µg/ml, respectively. Fluorescence imaging and visualization were conducted using multiphoton microscopy (Zeiss LMS 510 multiphoton microscope) at λex/λem(nm) 485/525 for Bodipy and 740/488 for filipin. Fluorescence intensity was quantified using Image-Pro software as done in our previous study [28] .
PCR Array Identification of Cell Cycle-Regulating Genes
PCR array is a real-time PCR-based gene expression analysis technique that uses a 96-well plate precoated with specific primers of genes of interest. By mixing cDNA templates and PCR reaction components together, the profile of gene expressions could be revealed through real-time PCR cycling reactions. Total RNA from macrophages treated with free cholesterol at 20µg/ml for 12 h was extracted with Trizol. The synthesized first strand cDNA was used to constitute the PCR reaction according to the manufacturer's manual. The PCR cycling reactions were conducted as follows: Denaturation at 95 
Macrophage Cell Viability Determination by WST Analysis and Viable Cell Counting
The concentration-dependent effects of free cholesterol on macrophage viability were quantified by measuring the formation of the tetrazolium metabolite formazan [29] and flow cytometry cell counting. Macrophages were split into 96-well plates with 2.5×10 4 cells/well and cultured 12 h prior to the addition of free cholesterol at the concentrations (µg/µl) 0, 5, 10, 20, 40 and 60. 24 h later, tetrazolium-containing WST-1 premix was added to the cell culture medium by following the product's manual. After incubation for 1 h at 37℃ and 5% CO 2 , the formation of the formazan metabolite was determined by colorimetrical absorbance measurement at λ=480 nm and subtraction of background at λ=605nm (FilterMax F3, Molecular Devices). For viable cell counting, macrophage culture and free cholesterol treatments were conducted in the same manner as in the WST assay except that 35 mm-dishes were used. Guava ViaCount reagent was mixed with a plasma membrane-permeable and a plasma membrane-impermeable dye and then applied to stain free cholesterol-treated macrophages to differentiate viable cells from apoptotic ones; this application was performed according to the product's manual. After incubation for 30 min at room temperature, cell counting was conducted using the ViaCount module on a Guava EasyCyte flow cytometer.
Macrophage M1/M2 Polarization and Apoptosis Analysis by Flow Cytometry Assay
Free cholesterol-treated macrophages were collected by gentle scraping and centrifugation. After two PBS washes, cell pellets were re-suspended in 0.05% BSA-supplemented PBS buffer with 1×10 
ELISA Analysis of IL-1β Secretions from Macrophages in Culture
Macrophages were sub-cultured into 6-well plates at 5x10 5 cells/well. 12 h after free cholesterol treatments, the culture medium was collected for IL-1β quantification with IL-1β ELISA kit according to the manufacturer's instructions and our previous study [33] . In brief, IL-1β-containing culture medium was added to a microplate strip, 100µl/well, incubated for 2 h at room temperature, mixed with IL-1β conjugate, and then incubated for another 2 h at room temperature. Thorough washes were performed between and after the two incubations. 100µl of substrate solution was applied to generate chemiluminescence. Chemiluminescent absorbance was determined using a microplate reader at (nm) λ=450, corrected to readings at λ=570. The IL-1β was quantified by relating the sample readings to the generated standard curve.
Cyclin E1 and PPARγ Expressions by Real-Time PCR and Western Blot Assay
In analyzing cyclin E1 and PPARγ, the total RNA and proteins were extracted from macrophages 12 h-and 24 h-post free cholesterol treatments, respectively. The real-time PCR reaction and the Western blot assays were conducted according to our previous methods [34, 35] . The specific primer pairs used for the amplification of cyclin E1 and PPARγ were 5'-GGA AAA TCA GAC CAC CCAGA-3' and 5'-AGG ATG ACG CTG CAG AAAGT-3', and 5'-CTC CGT GAT GGA AGA CCACT-3' and 5'-CAA CCA TTG GGT CAG CTCTT-3', respectively. In Western blot, the cyclin E1 or PPARγ target band was visualized and quantified using an Odyssey Imager with the application of infrared fluorescent IRDye @ 680RD-conjugated secondary antibodies.
Statistics
Data were presented as mean ± SE. Significant differences between and within multiple groups were examined using ANOVA for repeated measures, followed by Duncan's multiple-range test. Student's t-test was used to evaluate the significance in differences between 2 groups of observations. P < 0.05 was considered statistically significant.
Results

Macrophage Free Cholesterol Accumulation upon Free Cholesterol Loading
To determine the effects of free cholesterol loading on cholesterol accumulation in macrophages, filipin and Bodipy 493/503 stainings were conducted to examine free cholesterol and cholesterol ester buildup, respectively. The confocal microscopy filipin images showed that the accumulation of free cholesterol increased across the gamut of the cholesterol concentrations applied, and the distribution of the accumulated free cholesterol changed from a smear pattern to compartmentalization-like aggregation with increased cholesterol loading. In contrast, the buildup of cholesterol ester reached a peak at around 20µg/ml of free cholesterol and decreased thereafter, as revealed by changes in lipid droplet sizes (Fig. 1A) . The accumulation of free cholesterol and cholesteryl ester was quantified by fluorescence intensity analysis of images from the filipin and Bodipy 493/503 stainings [36] (Fig. 1B and 1C) .
Concentration-Associated Dual Effects of Free Cholesterol on Macrophage Viability
The accumulation of cholesterol in macrophages and the buildup of lesional macrophages underscore the development of the atheroma. In advanced atherosclerotic lesions, cholesterol-laden apoptotic and necrotic macrophages are confined under a fibrous cap whose rupture can lead to thrombosis and cause acute cardiovascular incidents such as heart attacks and strokes. Given that advanced atheromas are made up of macrophages containing excessive free cholesterol and the significant consequences associated with these atherosclerotic Fig. 1 . Accumulation of cholesterol in macrophages upon free cholesterol loading. A: Confocal microscopy images showed that free cholesterol, stained blue by filipin, progressively accumulated in macrophages as applied free cholesterol concentrations increased from (in µg/ml) 0 to 60. As well, free cholesterol deposition changed from a smear pattern to compartmentalization-like aggregation. In contrast, the buildup of cholesteryl ester, stained green by bodipy 493/503, featured an increase and a subsequent decrease with greater cholesterol loading. B and C: Quantification of free cholesterol and cholesteryl ester buildup by fluorescence intensity analysis. (P<0.05, * vs. 0 group; # vs. 20 µg/ml group, n = 6).
lesions, it is necessary to examine free cholesterol buildup on macrophage viability. Using tetrazolium salt (WST) metabolite assay and direct cell counting flow cytometry, viable macrophages were quantified. WST is a substrate of succinate-tetrazolium reductase, which exists in the mitochondrial respiratory chain and is only metabolically active in viable cells. The absorbance readings for formazan production revealed that relative formazan generation increased from 1 to 1.40 ± 0.14 at concentrations (µg/ml) from 0 to 20 but decreased thereafter at higher concentrations to 0.92 ± 0.08 ultimately at 60 µg/ml (Fig. 2A) ; thus, low and high free cholesterol concentrations have opposing effects on macrophage viability. Flow cytometry results also showed that the relative number of viable macrophages was enhanced from 1 to 1.40 ± 0.32 but then reduced to 0.81 ± 0.11 at the same cholesterol concentrations (Fig. 2B) as mentioned above.
Free Cholesterol Promotes Macrophage Viability through Cyclin E1 Activation
Next, we further investigated the dual effects of free cholesterol on macrophage viability by examining the expression of genes key to cell cycle regulation using PCR array analysis. A the genes with the most profound changes in expressions included (folds of Ctrl, gene): 1.56, Cyclin D1; 1.73, Cyclin E1; and 1.42, cell division cycle 6 homolog upon 20µg/ml free cholesterol treatment. Of these genes, the expression of Cyclin E1 displayed the most significant increase and was selected for verification by real-time PCR and Western blot analysis. The results showed that normalized cyclin E1 RNA and protein levels were 1, 1.27 ± 0.12, 1.38 ± 0.20, 1.39 ± 0.03, 1.19 ± 0.12, and 0.92 ± 0.04 (Fig. 3A) and 1, 1.47 ± 0.24, 2.00 ± 0.49, 2.32 ± 0.27, 1.73 ± 0.34, and 1.40 ± 0.45 ( Fig. 3C) , respectively, corresponding to free cholesterol concentrations of (in µg/ ml) 0, 5, 10, 20, 40, and 60. Figure 3B was a representative image of cyclin E1 Western blot. Functionally, by blocking cyclin E1 expression, the proliferative effects of cholesterol on macrophages were significantly attenuated as measured by viable cell counting flow cytometry (Fig. 3D) .
The Distinct Profile of M1 and M2 Polarization upon Free Cholesterol Loading
Macrophages are heterogeneous in terms of their polarization. Many studies have demonstrated that both M1-and M2-polarized macrophages dynamically coexist in atherosclerotic lesions [37] [38] [39] . Functionally, these two subgroups of macrophages secrete distinct pro-or anti-inflammatory cytokines that have progressive or regressive effects on atherosclerosis. We, therefore, proceeded to determine the effect of free cholesterol buildup on macrophage polarization using fluorescence-activated cell sorting (FACS) assay. Figure 4A was a representative FACS diagram of polarized M1 and M2 populations. The summarized FACS results showed that M2 polarization was boosted from (%) 18.50 ± 1.34 to 22.90 ± 2.57 when cholesterol was loaded at low concentrations of (in µg/ml) 0 to 20, but was reduced at higher concentrations (Fig. 4B) . M1 polarization, however, was enhanced across the gamut of the tested cholesterol concentrations (Fig. 4C ).
There have been reports that the induction of the M2 phenotype is associated with the activation of the nuclear factor PPARγ [40] . We thus decided to explore the mechanisms underlying free cholesterol-induced M2 stimulation by testing the functional role of PPARγ. The results in Fig. 5A and 5C showed that the expressions of PPARγ in mRNA and protein progressively increased with free cholesterol treatment at concentrations from (in µg/ml) 0 to 20, but then gradually decreased with treatment at higher concentrations from (in µg/ml) 20 to 60. Fig. 5B was the representative Western blot image of PPARγ. It should be noted that these changes in PPARγ expressions correlated well with M2 activation. siRNA gene interference and pharmacological (GW9662) blocking of PPARγ significantly attenuated M2-boosted effects by free cholesterol at 20µg/ml (Fig. 5D) .
Free Cholesterol Concentration-Dependent Effects on Inflammation and Apoptosis M1 macrophages secrete pro-inflammatory cytokines that play critical roles in the pathogenesis of atherosclerosis. To elucidate the functional significances of macrophage polarization by free cholesterol, we examined the production of IL-1β, a prototypic pro-inflammatory cytokine, and analyzed macrophage apoptosis. The real-time PCR and ELISA analysis results (Fig. 6A and 6B) showed that IL-1β mRNA levels and protein secretions were concurrently enhanced with increases in free cholesterol concentration. Similarly, macrophage apoptosis as measured by TUNEL analysis of DNA integrity was concentration-dependently elevated by free cholesterol. Figure 7A : Flow cytometry diagram of apoptotic macrophages. Figure 7B : TUNEL analysis results showing that the percentage of apoptotic macrophages was markedly increased with the application of high concentrations of cholesterol.
Discussion
The present study demonstrated that free cholesterol exerts concentration-dependent diversification effects on macrophage viability, polarization, inflammation, and apoptosis.
Lower concentrations of free cholesterol enhanced macrophage viability and caused anti-inflammatory M2 activation while higher concentrations induced pro-inflammatory M1 activation and led to apoptosis.
Free cholesterol is water insoluble and thus cannot be directly administered for macrophage treatment. In the present study, a vehicle-based cholesterol/methyl-β-cyclodextrin hydrophilic complex was applied to load free cholesterol into macrophages. This free cholesterol delivery strategy was similar to approaches taken in other studies whe- re free cholesterol was used [23, 41, 42] . When free cholesterol was applied to macrophages, free cholesterol accumulation occurred along with the formation of cholesteryl ester-filled lipid droplets. The esterified cholesterol in lipid droplets might mainly stem from the catalysis of partially loaded free cholesterol by ACAT1, a major enzyme responsible for the conversion of free cholesterol to cholesterol ester on the macrophage endoplasmic reticulum. Since free cholesterol buildup underscores macrophage viability and phenotype changes, we sought to determine free cholesterol accumulation rather than quantify the amount of free cholesterol taken up by cells upon treatment. Moreover, we preferred biochemical stainings to chromatographic measurements [43, 44] in quantifying free cholesterol buildup because these direct stainings allowed us to visualize the different accumulation profiles between free cholesterol and cholesteryl ester. Using filipin staining, the accumulation of free cholesterol has been determined, revealing that free cholesterol and cholesterol ester accumulation in macrophages followed different patterns: While free cholesterol experienced a steady buildup, the deposition of cholesteryl ester increased to a peak and then gradually decreased as evidenced by shrunken lipid droplet sizes and attenuated Bodipy 493/504 fluorescence intensity. At this point, higher cholesterol concentrations were associated with both reduced bodipy intensity and increased macrophage apoptosis; though, it might be argued it was the enhanced cell death that led to the decrease of Bodipy intensity. In apoptosis as well as necrosis, cell structures are disrupted, such as blebs formation and cell membrane and nucleus disintegration; however, these structural damages have nothing to do with alterations in lipid droplets. Therefore, the examined decrease in Bodipy staining was solely caused by the reduction in cholesteryl ester deposition. It has been reported that free cholesterol loading could disrupt the functions of the endoplasmic reticulum [45] , where the esterification of free cholesterol by ACAT1 takes place [8] . These results suggest that different levels of free cholesterol accumulation have profoundly different impacts on macrophages in the pathophysiology of atherosclerosis.
In this study, we investigated the effects of free cholesterol on macrophage viability and polarization within the concentration range of 0 to 60µg/ml; 60 µg/ml was established as the upper limit of this range since higher free cholesterol concentrations cause severe cytotoxicity and result in significant cell death. We found that M2 macrophage polarization increased at lower free cholesterol concentrations to a peak and then gradually decreased at higher concentrations. Our findings were consistent with one study showing that free cholesterol 'deactivated' and suppressed inflammatory-response genes, which implied the induction of the M2 phenotype [23] . It is noteworthy that the concentration of free cholesterol used in the said study ranged from (in µg/ml) 0 to 30, which was close to the concentrations over which M2 activation was observed in our study. Therefore, the induction of the M2 macrophage phenotype by cholesterol was solely associated with the application of low levels of free cholesterol.
There have been reports that the mechanisms underlying the activation of M2 include the Th2-cytokine IL4-associated PPARγ pathway [40] and desmosterol-mediated LXR signaling [23] . In our study, we found that free cholesterol exerted concentrationdependent boosting or inhibitive effects on the expression PPARγ and orchestrated the generation of the M2 phenotype, which represents a novel mechanism for M2 activation. The concentration range of free cholesterol favoring the M2 phenotype was very limited, beyond which significant increases in the M1 phenotype occurred. Consistently, the expression of the pro-inflammatory cytokine IL-1β concurrently increased. It was noteworthy that, at lower concentrations of free cholesterol treatment (0 -20 µg/ml), IL-1β secretions also experienced some increases. These moderate increases may be associated with slight rises in the number of M1 macrophages at low concentrations of cholesterol treatment. However, these moderate increases were distinctly different from the robust secretions of IL-1β at higher free cholesterol treatment (20 -60 µg/ml). These results collectively indicated that higher levels of cholesterol had pro-atherosclerotic effects. These results also agreed with long-standing observations that more accumulated free cholesterol and M1 macrophages were found in advanced atheroma [9] [10] [11] 46] .
Our macrophage viability results showed that the application of low concentrations of free cholesterol increased macrophage viability, which was reflected in macrophage proliferation -an event involved in macrophage accumulation in atherosclerotic lesions [47] -while high concentrations of free cholesterol led to cell apoptosis. Flow cytometry results demonstrated that free cholesterol at lower concentrations increased M2 polarization, but at higher concentrations induced M1 polarization. Therefore, apoptosis might have more profound effects on M2 than M1 macrophages. These described simultaneous events may be behind the concentration-dependent effects of free cholesterol in macrophages in atherosclerosis. There may exist some concerns about TUNEL's inability to distinguish Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry between cell apoptosis and necrosis. However, macrophage death from either apoptosis or necrosis upon high free cholesterol treatment will likely have the same consequences: Reducing the numbers of M2 type macrophages and increasing the numbers of proinflammatory M1 macrophages. In summary, this study for the first time examined the effects of free cholesterol on macrophage viability and polarization across a broad concentration range. We demonstrated that free cholesterol has concentration-dependent diversification effects on macrophage viability and polarization, thereby reconciling the pros and cons of free cholesterol toward atherogenesis. Understanding these concentration-dependent effects of cholesterol on atherosclerosis will facilitate the development of a free cholesterol-based therapy for preventing and treating atherosclerosis.
